Nasdaq · CIK 0001626450
CMRC Commerce.com, Inc.
Insider trading from SEC Form 4. Last filing 19 d ago. Close $3.48 on Oct 9, 2026, +69% from the 52-week low and -37% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
CMRCOct 9, 2026 · close 3.48
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Commerce.com, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Russell Scott Klein Chief Commercial Officer sell | $450k 98,080 shares | -18% | +10% from low-41% from high | |
| 60Notable | Lawrence S Bohn director sell | $6.0M 1,200,000 shares | -100% | +2% from low-35% from high | |
| 55Moderate | Ellen F Siminoff Executive Chair buy | $1.2M 177,158 shares | +233% | - | |
| 32Weak | Ellen F Siminoff Executive Chair buy | $148k 22,842 shares | +43% | - |
Transactions
The last 69 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Charles D Cassidy General Counsel and Secretary | FTax withholding Series 1 Common Stock | -281 | $3.33 | $936 | 165,043 | 19 d ago |
| Sep 21, 2025 | Charles D Cassidy General Counsel and Secretary | FTax withholding Series 1 Common Stock | -405 | $5.03 | $2,037 | 93,813 | Sep 23, 2025 |
| Sep 12, 2025 | Russell Scott Klein Chief Commercial Officer | MOption exercise Series 1 Common Stock | +98,080 | $0.39 | $38k | 542,081 | Sep 16, 2025 |
| Sep 12, 2025 | Russell Scott Klein Chief Commercial Officer | SOpen-market sale Series 1 Common Stock | -98,080 | $4.59 | $450k | 444,001 | Sep 16, 2025 |
| Sep 12, 2025 | Russell Scott Klein Chief Commercial Officer | MOption exercise Non-Qualified Stock Optionderivative | -98,080 | $4.59 | $450k | 0 | Sep 16, 2025 |
| Sep 10, 2025 | Ellen F Siminoff Executive Chair | AGrant or award Stock Option (Right to Buy)derivative | +247,963 | $0.00 | $0 | 247,963 | Sep 12, 2025 |
| Aug 21, 2025 | Hubert S Ban Chief Accounting Officer | FTax withholding Series 1 Common Stock | -2,846 | $4.54 | $13k | 52,649 | Aug 25, 2025 |
| Aug 14, 2025 | Donald E Clarke director | AGrant or award Series 1 Common Stock | +3,169 | $0.00 | $0 | 126,660 | Aug 18, 2025 |
| Aug 14, 2025 | Sarah Gilligan director | AGrant or award Series 1 Common Stock | +2,485 | $0.00 | $0 | 112,657 | Aug 18, 2025 |
| Aug 14, 2025 | Satish Malhotra director | AGrant or award Series 1 Common Stock | +2,535 | $0.00 | $0 | 111,585 | Aug 18, 2025 |
| Aug 14, 2025 | Anil Kamath director | AGrant or award Series 1 Common Stock | +73,550 | $0.00 | $0 | 73,550 | Aug 18, 2025 |
| Jun 30, 2025 | Daniel Lentz Chief Financial Officer | FTax withholding Series 1 Common Stock | -3,339 | $5.00 | $17k | 256,501 | Jul 2, 2025 |
| Jun 5, 2025 | Donald E Clarke director | AGrant or award Series 1 Common Stock | +34,337 | $0.00 | $0 | 120,532 | Jun 9, 2025 |
| Jun 5, 2025 | Satish Malhotra director | AGrant or award Series 1 Common Stock | +2,012 | $0.00 | $0 | 74,713 | Jun 9, 2025 |
| Jun 5, 2025 | Sarah Gilligan director | AGrant or award Series 1 Common Stock | +2,320 | $0.00 | $0 | 75,835 | Jun 9, 2025 |
| Jun 5, 2025 | Sarah Gilligan director | AGrant or award Series 1 Common Stock | +34,337 | $0.00 | $0 | 110,172 | Jun 9, 2025 |
| Jun 5, 2025 | Donald E Clarke director | AGrant or award Series 1 Common Stock | +2,959 | $0.00 | $0 | 123,491 | Jun 9, 2025 |
| Jun 5, 2025 | Satish Malhotra director | AGrant or award Series 1 Common Stock | +34,337 | $0.00 | $0 | 109,050 | Jun 9, 2025 |
| Jun 3, 2025 | Christopher Travis Hess Chief Exec Officer | FTax withholding Series 1 Common Stock | -21,932 | $5.05 | $111k | 502,173 | Jun 5, 2025 |
| Jun 2, 2025 | Lawrence S Bohn director | SOpen-market sale Series 1 Common Stockindirect: By General Catalyst Group V Supplemental, L.P. | -176,208 | $5.01 | $883k | 1,023,792 | Jun 4, 2025 |
| Jun 2, 2025 | Charles D Cassidy General Counsel and Secretary | FTax withholding Series 1 Common Stock | -1,463 | $5.00 | $7,315 | 94,218 | Jun 4, 2025 |
| Jun 3, 2025 | Lawrence S Bohn director | SOpen-market sale Series 1 Common Stockindirect: By General Catalyst Group V Supplemental, L.P. | -1,023,792 | $5.01 | $5.1M | 0 | Jun 4, 2025 |
| Mar 21, 2025 | Daniel Lentz Chief Financial Officer | FTax withholding Series 1 Common Stock | -8,091 | $5.99 | $48k | 259,840 | Mar 25, 2025 |
| Mar 21, 2025 | Brian Singh Dhatt Chief Technology Officer | FTax withholding Series 1 Common Stock | -15,076 | $5.99 | $90k | 263,386 | Mar 25, 2025 |
| Mar 21, 2025 | Russell Scott Klein Chief Commercial Officer | FTax withholding Series 1 Common Stock | -20,274 | $5.99 | $121k | 444,001 | Mar 25, 2025 |
| Mar 21, 2025 | Charles D Cassidy General Counsel & Secretary | FTax withholding Series 1 Common Stock | -1,269 | $5.99 | $7,601 | 95,681 | Mar 25, 2025 |
| Mar 21, 2025 | Hubert S Ban Chief Accounting Officer | FTax withholding Series 1 Common Stock | -597 | $5.99 | $3,576 | 55,495 | Mar 25, 2025 |
| Mar 6, 2025 | Ellen F Siminoff Executive Chair | POpen-market purchase Series 1 Common Stockindirect: By The D & E Living Trust | +177,158 | $6.64 | $1.2M | 253,333 | Mar 10, 2025 |
| Feb 27, 2025 | Charles D Cassidy General Counsel & Secretary | AGrant or award Series 1 Common Stock | +26,636 | $0.00 | $0 | 92,379 | Mar 3, 2025 |
| Feb 27, 2025 | Christopher Travis Hess Chief Exec Officer | AGrant or award Series 1 Common Stock | +140,187 | $0.00 | $0 | 500,451 | Mar 3, 2025 |
| Feb 27, 2025 | Daniel Lentz Chief Financial Officer | AGrant or award Series 1 Common Stock | +70,093 | $0.00 | $0 | 244,045 | Mar 3, 2025 |
| Feb 27, 2025 | Robert Walter Chief Revenue Officer | AGrant or award Series 1 Common Stock | +27,000 | $0.00 | $0 | 27,000 | Mar 3, 2025 |
| Feb 27, 2025 | Brian Singh Dhatt Chief Technology Officer | AGrant or award Series 1 Common Stock | +26,168 | $0.00 | $0 | 267,009 | Mar 3, 2025 |
| Feb 27, 2025 | Satish Malhotra director | AGrant or award Series 1 Common Stock | +1,649 | $0.00 | $0 | 72,701 | Mar 3, 2025 |
| Feb 27, 2025 | Sarah Gilligan director | AGrant or award Series 1 Common Stock | +1,746 | $0.00 | $0 | 73,515 | Mar 3, 2025 |
| Feb 27, 2025 | Donald E Clarke director | AGrant or award Series 1 Common Stock | +2,135 | $0.00 | $0 | 86,195 | Mar 3, 2025 |
| Feb 27, 2025 | Hubert S Ban Chief Accounting Officer | AGrant or award Series 1 Common Stock | +17,290 | $0.00 | $0 | 52,939 | Mar 3, 2025 |
| Feb 27, 2025 | Russell Scott Klein Chief Commercial Officer | AGrant or award Series 1 Common Stock | +28,972 | $0.00 | $0 | 454,860 | Mar 3, 2025 |
| Feb 27, 2025 | Hubert S Ban Chief Accounting Officer | AGrant or award Series 1 Common Stock | +5,352 | $0.00 | $0 | 58,291 | Mar 3, 2025 |
| Feb 27, 2025 | Brian Singh Dhatt Chief Technology Officer | AGrant or award Series 1 Common Stock | +21,409 | $0.00 | $0 | 288,418 | Mar 3, 2025 |
| Feb 27, 2025 | Charles D Cassidy General Counsel & Secretary | AGrant or award Series 1 Common Stock | +6,499 | $0.00 | $0 | 98,878 | Mar 3, 2025 |
| Feb 27, 2025 | Robert Walter Chief Revenue Officer | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Mar 3, 2025 |
| Feb 27, 2025 | Russell Scott Klein Chief Commercial Officer | AGrant or award Series 1 Common Stock | +19,880 | $0.00 | $0 | 474,740 | Mar 3, 2025 |
| Feb 27, 2025 | Daniel Lentz Chief Financial Officer | AGrant or award Series 1 Common Stock | +32,876 | $0.00 | $0 | 276,921 | Mar 3, 2025 |
| Feb 27, 2025 | Christopher Travis Hess Chief Exec Officer | AGrant or award Series 1 Common Stock | +32,110 | $0.00 | $0 | 532,561 | Mar 3, 2025 |
| Feb 27, 2025 | Hubert S Ban Chief Accounting Officer | FTax withholding Series 1 Common Stock | -2,199 | $7.09 | $16k | 56,092 | Mar 3, 2025 |
| Feb 27, 2025 | Christopher Travis Hess Chief Exec Officer | FTax withholding Series 1 Common Stock | -8,456 | $7.09 | $60k | 524,105 | Mar 3, 2025 |
| Feb 27, 2025 | Russell Scott Klein Chief Commercial Officer | FTax withholding Series 1 Common Stock | -7,419 | $7.09 | $53k | 467,321 | Mar 3, 2025 |
| Feb 27, 2025 | Charles D Cassidy General Counsel & Secretary | FTax withholding Series 1 Common Stock | -1,928 | $7.09 | $14k | 96,950 | Mar 3, 2025 |
| Feb 27, 2025 | Daniel Lentz Chief Financial Officer | FTax withholding Series 1 Common Stock | -8,550 | $7.09 | $61k | 268,371 | Mar 3, 2025 |
| Feb 27, 2025 | Brian Singh Dhatt Chief Technology Officer | FTax withholding Series 1 Common Stock | -8,128 | $7.09 | $58k | 280,290 | Mar 3, 2025 |
| Feb 27, 2025 | Charles D Cassidy General Counsel & Secretary | AGrant or award Stock Option (Right to Buy)derivative | +28,363 | $0.00 | $0 | 28,363 | Mar 3, 2025 |
| Feb 27, 2025 | Hubert S Ban Chief Accounting Officer | AGrant or award Stock Option (Right to Buy)derivative | +18,411 | $0.00 | $0 | 18,411 | Mar 3, 2025 |
| Feb 27, 2025 | Christopher Travis Hess Chief Exec Officer | AGrant or award Stock Option (Right to Buy)derivative | +149,277 | $0.00 | $0 | 149,277 | Mar 3, 2025 |
| Mar 1, 2025 | Russell Scott Klein Chief Commercial Officer | FTax withholding Series 1 Common Stock | -3,046 | $7.08 | $22k | 464,275 | Mar 3, 2025 |
| Mar 1, 2025 | Daniel Lentz Chief Financial Officer | FTax withholding Series 1 Common Stock | -440 | $7.08 | $3,115 | 267,931 | Mar 3, 2025 |
| Mar 1, 2025 | Brian Singh Dhatt Chief Technology Officer | FTax withholding Series 1 Common Stock | -1,828 | $7.08 | $13k | 278,462 | Mar 3, 2025 |
| Feb 27, 2025 | Daniel Lentz Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +74,638 | $0.00 | $0 | 74,638 | Mar 3, 2025 |
| Feb 27, 2025 | Brian Singh Dhatt Chief Technology Officer | AGrant or award Stock Option (Right to Buy)derivative | +27,865 | $0.00 | $0 | 27,865 | Mar 3, 2025 |
| Feb 27, 2025 | Russell Scott Klein Chief Commercial Officer | AGrant or award Stock Option (Right to Buy)derivative | +30,850 | $0.00 | $0 | 30,850 | Mar 3, 2025 |
| Feb 24, 2025 | Ellen F Siminoff Executive Chair | POpen-market purchase Series 1 Common Stockindirect: By The D & E Living Trust | +3,239 | $6.28 | $20k | 56,572 | Feb 26, 2025 |
| Feb 25, 2025 | Ellen F Siminoff Executive Chair | POpen-market purchase Series 1 Common Stockindirect: By The D & E Living Trust | +19,603 | $6.49 | $127k | 76,175 | Feb 26, 2025 |
| Nov 21, 2024 | Satish Malhotra director | AGrant or award Series 1 Common Stock | +1,857 | $0.00 | $0 | 71,052 | Nov 25, 2024 |
| Nov 21, 2024 | Sarah Gilligan director | AGrant or award Series 1 Common Stock | +1,966 | $0.00 | $0 | 71,769 | Nov 25, 2024 |
| Nov 21, 2024 | Donald E Clarke director | AGrant or award Series 1 Common Stock | +2,403 | $0.00 | $0 | 84,060 | Nov 25, 2024 |
| Nov 21, 2024 | Ellen F Siminoff Executive Chair | AGrant or award Series 1 Common Stock | +2,207 | $0.00 | $0 | 77,986 | Nov 25, 2024 |
| Nov 13, 2024 | Christopher Travis Hess President | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Nov 15, 2024 |
| Nov 13, 2024 | Ellen F Siminoff Executive Chair | AGrant or award Stock Option (Right to Buy)derivative | +190,000 | $0.00 | $0 | 190,000 | Nov 15, 2024 |
| Nov 11, 2024 | Daniel Lentz Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +16,160 | $0.00 | $0 | 16,160 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Lawrence S Bohndirector
- Hubert S BanChief Accounting Officer
- Charles D CassidyGeneral Counsel and Secretary
- Donald E Clarkedirector
- Brian Singh DhattChief Technology Officer
- Sarah Gilligandirector, officer
- Christopher Travis HessChief Exec Officer
- Anil Kamathdirector
- Russell Scott KleinChief Commercial Officer
- Daniel LentzChief Financial Officer
- Satish Malhotradirector
- Ellen F SiminoffExecutive Chair
- Robert WalterChief Revenue Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.